Espinosa-Gil, Sergio; Ivanova, Saska; Alari-Pahissa, Elisenda; Denizli, Melek; Villafranca-Magdalena, Beatriz; Viñas-Casas, Maria; Bolinaga-Ayala, Idoia; Gámez-García, Andrés; Faundez-Vidiella, Claudia; Colas, Eva; López-Botet, M. (Miguel); Zorzano, Antonio; Lizcano, José Miguel
(Nature Research, 2023)
Death receptor ligand TRAIL is a promising cancer therapy due to its ability to selectively trigger extrinsic apoptosis in cancer cells. However, TRAIL-based therapies in humans have shown limitations, mainly due inherent ...